LEADER 04024nam 2200637 450 001 9910789364303321 005 20230803034701.0 010 $a0-309-26949-0 010 $a0-309-26946-6 035 $a(CKB)3710000000103241 035 $a(EBL)3379099 035 $a(SSID)ssj0001004838 035 $a(PQKBManifestationID)12486287 035 $a(PQKBTitleCode)TC0001004838 035 $a(PQKBWorkID)11046596 035 $a(PQKB)11304490 035 $a(MiAaPQ)EBC3379099 035 $a(Au-PeEL)EBL3379099 035 $a(CaPaEBR)ebr10863748 035 $a(OCoLC)880439882 035 $a(EXLCZ)993710000000103241 100 $a20140130h20132013 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDelivering Affordable Cancer Care in the 21st Century $eworkshop summary /$fErin Balogh, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies 210 1$aWashington, District of Columbia :$cNational Academies Press,$d[2013] 210 4$dİ2013 215 $a1 online resource (94 p.) 300 $aDescription based upon print version of record. 311 $a0-309-26944-X 320 $aIncludes bibliographical references (pages 67-74). 327 $aIntroduction -- A financial crisis in health care -- Drivers of health care costs -- Cancer care costs -- Financial burden on patients with cancer -- Questionable value -- Current challenges -- Inappropriate incentives -- Unrealistic expectations -- Overuse and misuse of interventions -- Variable care, lack of best practices, and an inadequate evidence base -- Legal and regulatory issues -- Assessing value -- Possible solutions -- Patient and clinician communication and education -- Best practices in cancer care -- Evidence base for clinical practice and reimbursement -- Financial incentives aligned with affordable, high-quality cancer care -- Delivery system and reimbursement changes -- Wrap up. 330 $a"Rising health care costs are a central fiscal challenge confronting the United States. National spending on health care currently accounts for 18 percent of gross domestic product (GDP), but is anticipated to increase to 25 percent of GDP by 2037. The Bipartisan Policy Center argues that "this rapid growth in health expenditures creates an unsustainable burden on America's economy, with far-reaching consequences". These consequences include crowding out many national priorities, including investments in education, infrastructure, and research; stagnation of employee wages; and decreased international competitiveness. In spite of health care costs that far exceed those of other countries, health outcomes in the United States are not considerably better. With the goal of ensuring that patients have access to high-quality, affordable cancer care, the Institute of Medicine's (IOM's) National Cancer Policy Forum convened a public workshop, Delivering Affordable Cancer Care in the 21st Century, October 8-9, 2012, in Washington, DC. Delivering Affordable Cancer Care in the 21st Century summarizes the workshop"--$cPublisher's description. 606 $aCancer$xTreatment$vCongresses 606 $aMedical care, Cost of$vCongresses 606 $aMedical care$xFinance$vCongresses 615 0$aCancer$xTreatment 615 0$aMedical care, Cost of 615 0$aMedical care$xFinance 676 $a616.99406 702 $aBalogh$b Erin 702 $aPatlak$b Margie 702 $aNass$b Sharyl J. 712 02$aNational Cancer Policy Forum (U.S.), 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Care Services, 712 12$aDelivering Affordable Cancer Care in the 21st Century (Workshop) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789364303321 996 $aDelivering Affordable Cancer Care in the 21st Century$93788905 997 $aUNINA